Acobiom
PrivateLast Round
Grant
Jul 20, 2026
Total Funding Raised
$1.27M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Acobiom is a biotechnology company that specializes in the discovery of biomarkers and the development of innovative diagnostic tests for precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acobiom Comparables
Compare Acobiom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Firalis | 88% | |
| Explicyte Immuno-Oncology | 79% | |
| Genevia Technologies | 78% |
Acobiom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 20, 2026 | ||||
| Early Funding | Mar 14, 2023 | ||||
| Grant | May 11, 2021 | ||||
| Crowdfunding | Apr 1, 2020 | ||||
| Grant | Feb 1, 2017 |
Acobiom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| EIT Health | Grant |
| European Partnership for Personalised Medicine | Grant |
| European Union | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Received funding from EIT Health, European Union, and EPPM.
- Feb 8, 2026
Grew 100% QoQ, from 3 to 6 employees.
Acobiom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Acobiom's valuation, stock price, and market status.
Is Acobiom a public or private company?
Acobiom is a private company.
What is the current stock price of Acobiom?
Acobiom is a private company with no public stock price. Caplight tracks Acobiom's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Acobiom worth (valuation)?
Valuation information for Acobiom is not publicly available.
Can I buy Acobiom stock?
Acobiom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Acobiom's last funding round?
Acobiom's most recent funding round was Grant on July 20, 2026.
Who are the main investors in Acobiom?
Key investors in Acobiom include European Commission, EIT Health, European Partnership for Personalised Medicine, European Union, Bpifrance.
Will Acobiom IPO soon?
No public IPO plans have been announced for Acobiom.
How can I track Acobiom secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Acobiom's secondary market activity and sign up for updates.